ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2309건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 69 | Completed | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection | Viral Respiratory Illnesses | Drug: Nitazoxanide Drug: Placebo Dietary Supplement: Vitamin Super B-Complex |
Phase 3 | Romark Laboratories L.C. | INDUSTRY | 1407 | All | 18 Years ~ 120 Years | HealthStar Research LLC, Hot Springs, Arkansas, United States So Cal Clinical Research, Huntington Beach, California, United States Long Beach Clinical Trials, LLC, Long Beach, California, United States Meris Clinical Research, Brandon, Florida, United States Invesclinica US LLC, Fort Lauderdale, Florida, United States The Chappel Group Research, Kissimmee, Florida, United States New Horizon Research Center, Miami, Florida, United States Clinical Neuroscience Solutions, Inc., Orlando, Florida, United States DMI Research, Pinellas Park, Florida, United States Tampa General Hospital, Tampa, Florida, United States Chicago Clinical Research Institute, Inc., Chicago, Illinois, United States Chicago Medical Research Institute, Inc., Chicago, Illinois, United States Quad Clinical Research, Chicago, Illinois, United States Chicago Medical Research, LLC, Hazel Crest, Illinois, United States Centex Studies, Inc., Lake Charles, Louisiana, United States Vida Clinical Studies, Dearborn, Michigan, United States Beacom Family Health Connection, Fremont, Nebraska, United States North Jersey Community Research Initiative, Newark, New Jersey, United States RH Medical Urgent Care Professional PLLC, Bronx, New York, United States Integrative Clinical Trials LLC, Brooklyn, New York, United States The New York Center for Travel and Tropical Medicine, New York, New York, United States Centex Studies, Inc., Houston, Texas, United States SMS Clinical Research LLC, Mesquite, Texas, United States LinQ Research LLC, Pearland, Texas, United States Rio Grande Valley Clinical Research Institute, Pharr, Texas, United States BFHC Research, San Antonio, Texas, United States |
| 68 | Completed | Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) | Virus Diseases | Drug: Maraviroc experimental group Other: Standard treatment |
Phase 2 | Fundacion Publica Andaluza para la gestion de la Investigacion en Sevilla | OTHER | 44 | All | 18 Years | Hospital Universitario Virgen del Rocio, Sevilla, Spain Hospital Universitario Virgen del Rocio, Sevilla, Spain |
| 67 | Withdrawn | Trial to Promote Recovery From COVID-19 With Endocrine Therapy | SARS-CoV 2 | Drug: Bicalutamide 150 Mg Oral Tablet | Phase 2 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | OTHER | 0 | All | 18 Years | Johns Hopkins Hospital, Baltimore, Maryland, United States |
| 66 | Completed | Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19 | COVID-19 | Drug: Standard COVID-19 care Dietary Supplement: Quercetin Phytosome |
Phase 3 | Liaquat University of Medical & Health Sciences | OTHER | 152 | All | 18 Years | Liaquat University Hospital, J?mshoro, Sindh, Pakistan |
| 65 | Completed | Trial to Study the Benefit of Colchicine in Patients With COVID-19 | COVID19 | Drug: Colchicine Tablets Drug: Standard therapy for COVID-19 according to the stablished hospital protocols. |
Phase 3 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | OTHER | 102 | All | 18 Years | Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain |
| 64 | Terminated | Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection | Covid-19 | Drug: T3 solution for injection Drug: Placebo |
Phase 2 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A., Attikon Hospital | INDUSTRY | 5 | All | 18 Years | Attikon University General Hospital, Haidari/Athens, Greece |
| 63 | Terminated | TXA and Corona Virus 2019 (COVID19) in Outpatients | COVID-19 | Drug: Tranexamic acid tablets Drug: Placebo oral tablet |
Phase 2 | University of Alabama at Birmingham | OTHER | 5 | All | 19 Years | University of Alabama at Birmingham, Birmingham, Alabama, United States |
